The biotechnology industry is one of the riskiest and the most challenging—but it is also one of the few that makes the difference between life and death.
In recent years, biotech has given us major breakthroughs: vaccines that provide protection from lethal viruses; a lupus treatment approved for use in children with the first new mechanism of action in more than 50 years; and significant progress in hematology with the approval of a bispecific antibody for multiple myeloma.
Image: Dinesh Patel, PhD, CEO of Protagonist Therapeutics (PTGX)
{iframe}https://bio.news/editors-choice/predictions-for-biotech-2023-2022-was-a-challenging-year-for-biotechnology/{/iframe}